These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 22131939)

  • 41. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD007807. PubMed ID: 28752910
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxidative mechanisms and tardive dyskinesia.
    Lohr JB; Kuczenski R; Niculescu AB
    CNS Drugs; 2003; 17(1):47-62. PubMed ID: 12467492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia.
    Lister J; Andreazza AC; Navaid B; Wilson VS; Teo C; Nesarajah Y; Wilson AA; Nobrega JN; Fletcher PJ; Remington G
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jan; 72():23-29. PubMed ID: 27565433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of omega-3 polyunsaturated fatty acids supplements on psychopathology and metabolic parameters in schizophrenia: A meta-analysis of randomized controlled trials.
    Goh KK; Chen CY; Chen CH; Lu ML
    J Psychopharmacol; 2021 Mar; 35(3):221-235. PubMed ID: 33586517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
    De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU
    CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vitamin E for antipsychotic-induced tardive dyskinesia.
    Soares-Weiser K; Maayan N; Bergman H
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000209. PubMed ID: 29341067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Free radical pathology in schizophrenia: a review.
    Reddy RD; Yao JK
    Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):33-43. PubMed ID: 8888121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.
    Yao JK; Reddy RD; van Kammen DP
    CNS Drugs; 2001; 15(4):287-310. PubMed ID: 11463134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2.
    Pham DQ; Plakogiannis R
    Ann Pharmacother; 2005 Dec; 39(12):2065-72. PubMed ID: 16288072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin E for neuroleptic-induced tardive dyskinesia.
    Soares KV; McGrath JJ
    Cochrane Database Syst Rev; 2000; (2):CD000209. PubMed ID: 10796508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antioxidants for male subfertility.
    Smits RM; Mackenzie-Proctor R; Yazdani A; Stankiewicz MT; Jordan V; Showell MG
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD007411. PubMed ID: 30866036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-neuroleptic catecholaminergic drugs for neuroleptic-induced tardive dyskinesia.
    El-Sayeh HG; Lyra da Silva JP; Rathbone J; Soares-Weiser K
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000458. PubMed ID: 16437424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxidative injury and potential use of antioxidants in schizophrenia.
    Mahadik SP; Scheffer RE
    Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):45-54. PubMed ID: 8888122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome.
    Rahmani E; Samimi M; Ebrahimi FA; Foroozanfard F; Ahmadi S; Rahimi M; Jamilian M; Aghadavod E; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z
    Mol Cell Endocrinol; 2017 Jan; 439():247-255. PubMed ID: 27619403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients.
    Ranjekar PK; Hinge A; Hegde MV; Ghate M; Kale A; Sitasawad S; Wagh UV; Debsikdar VB; Mahadik SP
    Psychiatry Res; 2003 Dec; 121(2):109-22. PubMed ID: 14656446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study.
    Sivrioglu EY; Kirli S; Sipahioglu D; Gursoy B; Sarandöl E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1493-9. PubMed ID: 17688987
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.